Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kaifeng Jin
Observed name:
Jin, Kaifeng
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Zhongshan Hospital
Observed institutions:
Shanghai Medical College of Fudan University,
Hebrew University of Jerusalem,
Fudan University,
Zhongshan Hospital
ORCID:
0000-0001-9867-6516
Observed ORCID:
0000-0001-9867-6516
OpenAlex ID:
A5003840849
Robust estimation of bacterial cell count from optical density
2020
·
Jacob Beal
, Natalie G. Farny
, et al.
·
Communications Biology
·
362
PDF
Intratumoral CXCL13 + CD8 + T cell infiltration determines poor clinical outcomes and immunoevasive contexture in patients with clear cell renal cell carcinoma
2021
·
Siyuan Dai
, Han Zeng
, et al.
·
Journal for ImmunoTherapy of Cancer
·
260
PDF
Poor Clinical Outcomes and Immunoevasive Contexture in Intratumoral IL-10-Producing Macrophages Enriched Gastric Cancer Patients
2020
·
Hongyu Zhang
, Ruochen Li
, et al.
·
Annals of Surgery
·
188
Immunosuppressive tumor-associated macrophages expressing interlukin-10 conferred poor prognosis and therapeutic vulnerability in patients with muscle-invasive bladder cancer
2022
·
Yijia Xu
, Han Zeng
, et al.
·
Journal for ImmunoTherapy of Cancer
·
108
PDF
CD47 expression in gastric cancer clinical correlates and association with macrophage infiltration
2021
·
Mingsu Shi
, Yun Gu
, et al.
·
Cancer Immunology Immunotherapy
·
85
Infiltration and Polarization of Tumor-associated Macrophages Predict Prognosis and Therapeutic Benefit in Muscle-Invasive Bladder Cancer
2021
·
Mengmeng Sun
, Han Zeng
, et al.
·
Cancer Immunology Immunotherapy
·
52
CD103+CD8+ tissue-resident memory T cell infiltration predicts clinical outcome and adjuvant therapeutic benefit in muscle-invasive bladder cancer
2022
·
Kaifeng Jin
, Yanze Yu
, et al.
·
British Journal of Cancer
·
44
Poor clinical outcomes and immunoevasive contexture in CXCL13+CD8+ T cells enriched gastric cancer patients
2021
·
Kaifeng Jin
, Yifan Cao
, et al.
·
OncoImmunology
·
41
PDF
Lymphocyte‐activation gene 3 expression associates with poor prognosis and immunoevasive contexture in Epstein‐Barr virus‐positive and MLH1‐defective gastric cancer patients
2020
·
Kunpeng Lv
, Ruochen Li
, et al.
·
International Journal of Cancer
·
34
PDF
Intratumoral CD103 + CD4 + T cell infiltration defines immunoevasive contexture and poor clinical outcomes in gastric cancer patients
2020
·
Yun Gu
, Yifan Chen
, et al.
·
OncoImmunology
·
27
PDF
B7-H4 correlates with clinical outcome and immunotherapeutic benefit in muscle-invasive bladder cancer
2022
·
Zhaopei Liu
, Kaifeng Jin
, et al.
·
European Journal of Cancer
·
21
TIGIT and PD-1 expression atlas predicts response to adjuvant chemotherapy and PD-L1 blockade in muscle-invasive bladder cancer
2022
·
Zhaopei Liu
, Han Zeng
, et al.
·
British Journal of Cancer
·
19
NKG2A and PD-L1 expression panel predicts clinical benefits from adjuvant chemotherapy and PD-L1 blockade in muscle-invasive bladder cancer
2022
·
Sen Yan
, Han Zeng
, et al.
·
Journal for ImmunoTherapy of Cancer
·
18
PDF
Intratumoral interleukin-9 delineates a distinct immunogenic class of gastric cancer patients with better prognosis and adjuvant chemotherapeutic response
2020
·
H. Fang
, R. Li
, et al.
·
OncoImmunology
·
18
TP53 disruptive mutation predicts platinum‐based chemotherapy and PD‐1 / PD‐L1 blockade response in urothelial carcinoma
2024
·
Kaifeng Jin
, Jingtong Xu
, et al.
·
The Journal of Pathology
·
16
Author Correction: Robust estimation of bacterial cell count from optical density
2020
·
Jacob Beal
, Natalie G. Farny
, et al.
·
Communications Biology
·
14
PDF
Tumor-infiltrating podoplanin + cells in gastric cancer: clinical outcomes and association with immune contexture
2020
·
Xin Liu
, Yifan Cao
, et al.
·
OncoImmunology
·
14
PDF
Integrating molecular subtype and CD8+ T cells infiltration to predict treatment response and survival in muscle-invasive bladder cancer
2024
·
Bingyu Li
, Kaifeng Jin
, et al.
·
Cancer Immunology Immunotherapy
·
12
PDF
POLQ identifies a better response subset to immunotherapy in muscle‐invasive bladder cancer with high PD‐L1
2024
·
Ge Liu
, Kaifeng Jin
, et al.
·
Cancer Medicine
·
9
PDF
Integrative score based on CDK6, PD-L1 and TMB predicts response to platinum-based chemotherapy and PD-1/PD-L1 blockade in muscle-invasive bladder cancer
2024
·
Xiaohe Su
, Kaifeng Jin
, et al.
·
British Journal of Cancer
·
9
PDF
Immune inactivation by VISTA predicts clinical outcome and therapeutic benefit in muscle-invasive bladder cancer
2023
·
Wandi Li
, Zhaopei Liu
, et al.
·
BMC Cancer
·
9
PDF
Immune inactivation by neuropilin-1 predicts clinical outcome and therapeutic benefit in muscle-invasive bladder cancer
2022
·
Yanze Yu
, Han Zeng
, et al.
·
Cancer Immunology Immunotherapy
·
9
Lethal clinical outcome and chemotherapy and immunotherapy resistance in patients with urothelial carcinoma with MDM2 amplification or overexpression
2025
·
Kaifeng Jin
, Yawei Ding
, et al.
·
Journal for ImmunoTherapy of Cancer
·
7
PDF
Stromal Tumor-Associated Macrophage Infiltration Predicts Poor Clinical Outcomes in Muscle-Invasive Bladder Cancer Patients
2022
·
Shengming Jin
, Han Zeng
, et al.
·
Annals of Surgical Oncology
·
7
Gender disparities in clinical outcomes of urothelial carcinoma linked to X chromosome gene KDM6A mutation
2023
·
Zhaopei Liu
, Kaifeng Jin
, et al.
·
BMJ Oncology
·
5
Show more works
View as search
Works count:
52
Citation count:
1,426
H-index:
15
I10-index:
18
Year
Topic
Type